Member Info for Fruitsnveg

Go one, give a like if you're a REAL investor here.

Let's see how many there are on this forum.

Lol.

All IMHO.

Mani,

If I knew the manufacture date of SNG001 drug, rest assured, you and your chums would be the last people I'd share that info with.

I think LBC (or you) are telling porkies there Mani.

According to the latest official stats on UK Gov website "in week 52, influenza activity increased across most indicators, including hospital admissions. COVID-19 activity showed mixed activity, with stabilisation of test positivity rates and reported acute respiratory outbreaks, but slight increases in hospital and intensive care unit (ICU) or high

dependency unit (HDU) admissions. Respiratory syncytial virus (RSV) activity decreased in children aged under 5 years, while RSV hospital admissions increased in older adult groups."

Similarly, in the USA, In the last week of 2023 — through December 30 — there were nearly 35,000 new Covid-19 admissions and more than 20,000 new admissions for flu, according to CDC data.

I believe we are planning some studies in the US as well as UK, maybe someone could confirm?

Agree there Size82. I remain of the opinion that this is an all or nothing share. By 'all' I mean blockbuster - it will either meet a longstanding and costly global unmet clinical need, or it won't. That potential has not changed. There are many strings to the bows of research that are starting to come together. Few are reported on this forum, that does not negate their existence. 100p? I wouldn't dust off a petri dish for 100p if SNG001 is shown to BP to have blockbuster potential. Only time will tell.

Very interesting, I had no idea they were initially discounted as having "no pathological consequences"... Thank goodness people persist and challenge. Thanks for posting Brand.

Axe has been a self-confessed shorter of this stock for a long time, not much else to add really.

Yelps a lot, like Mani and the other yelpers.

Manicure, are you typing on an Olivetti typewriter with a shredded ribbon, because it sure looks like it?

But do carry on.....

If only Costas and Co had gone to the AGM, like they always say they will, then never do....

Not so novice a player after all, are you Prof?

"5mln convertible bond" you say? If only TFG had you as their advisor, they'd have already made back their loss.

Happy to oblige; they haven't made a loss, because they haven't sold. Simple. In fact, they added more, over quite a number of months. With such a low overall investment (compared to the rest of their fund allocations) that seems to be an act of conviction, rather than novice ineptitude.

I hope you enjoyed today's lesson Prof.

The larger the 'shop', the more sophisticated the hedging options generally employed. But of course you already know that. Its all in their fund analysis reports available on their website for those who don't. No serious loss here, not according to their own published accounts. Go have a read, you might learn something.

You say that as if the thought of a hedge fund generating consistent returns regardless of market direction through a combination of long and short positions, just occurred to you? What do you think the very clever people at TFG have been doing here for 3 years? A pre-requisite of course is minimal volatility, which, we just happen to be maintaining very well here, aided in o small part by the oddly incessant 'good cop bad cop' posting here.

As others are oft to say.....make of that what you will....

Mani is worried about dilution because then he'd end up with the square root of nothing, which is essentially how much he has invested in SNG; nothing. Spends the year yelping with the other yelpers, but can't be bothered to come to the AGM and state any kind of case, every year. Too busy dreaming up silly content for this forum. Yawn.

According to the company published financial report in September, Administrative expenses, which typically includes salaries and benefits etc, for the six months ended 30 June 2023 were £2.1 million (30 June 2022: £2.9 million), with the reduction being attributable to the pre-commercialisation activities incurred in 2022. Admin Expenses also typically includes things like rent, utilities, equipment, supplies, insurance policies, and legal counsel).

You also neglected to include the hefty tax rebate the company will get which adds back to the pile; note the research and development tax credit increased from £3.8 million to £9.2 million in 2022.

A lack of communication from RM could just as easily (and IMO much more likely) be to because of commercial sensitivity. We certainly don't want to be informing the uninvested, traders and competitors, no doubt both categories are well represented on this forum, ever eager to further erode the SP.

The heading to dilution narrative appears to be a theme of the majority of your posts on all the stocks you are "not shorting or invested in".

"Absolutely certain they received offers after SG016 - but they were hubristic and greedy. "

So certain yet you have ZERO evidence to back up that stupid repetitive claim. It's easy to make up crud and pass it as fact. Let's be having your evidence of this infamous OFFER. We'e all ears.

“MyAloneThoughts”.

So good Gunto.

So apt.

That's a very silly statement DocDaneeka, even for you. "Doubts remain that the company has the skillset ( it doesn't) or access to others with the skillset to design such novel tools". I certainly don't share those doubts . Do you think the UoS, MRC and the many other organisations and collegiate networks which SNG founders and esteemed staff have access have nothing to offer in this space? Really? Hmmm.... I don't think Synairgen staff are anywhere near as green and novice as you'd like to make out....

Yawn. So many uninvested shorters here today. I've not read this many desperate posts for a while. They seem intensely triggered. Tight Shorts? IMHO!

Let them get it all out, I think I'll come back in a week...